Contact information
fernando.ramoslopez@ndm.ox.ac.uk
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford OX3 7LE
Research groups
Fernando Ramos Lopez
BSc, RN, MSc
Senior Research Nurse
Recent publications
-
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.
Journal article
Datoo MS. et al, (2022), The Lancet. Infectious diseases, 22, 1728 - 1736
-
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial
Journal article
Jenkin D. et al, (2022), The Lancet Microbe, 3, e663 - e671
-
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
Journal article
Salkeld J. et al, (2022), Frontiers in Immunology, 13
-
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
Journal article
Bosaeed M. et al, (2022), The Lancet Microbe, 3, e11 - e20
-
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial.
Journal article
Bosaeed M. et al, (2022), The Lancet. Microbe, 3, e11 - e20